Thursday, December 1, 2016

Nature News highlights: 1 December 2016

If you are unable to see the message below, click here to view.

  01 December 2016    
 

nature news alert

• Read Nature's news online
• Subscribe to Nature

Your weekly update from Nature's global news team.

 
     
 
 
 
Maximize culture quality and minimize daily feeding.

StemBeads® are developed and tested by scientists who understand the complexity of cells and the importance of high quality reagents.
  • Reduce Spontaneous Differentiation and Cell Death
  • Improve Culture Quality
  • Use your Favorite Media
  • Media savings of up to 67%
  • Save Time and Money

Watch our video and learn more

 
 
 
 
 
LDI Multiline Laser Illuminator for spinning disk confocal, photactivation, optogenetics, TIRF, PALM/STORM. High power/Low cost. Up to 1W of power per channel, feedback controlled stability, up to 7 wavelengths, ultimate price to performance ratio.
 
 
  • Latest News  
 
 
 
 
 
 

Deforestation spikes in Brazilian Amazon ▶

30 November 2016
 
 

Illegal land clearing hits its highest levels since 2008 as environmental policies come under attack. Read More ▶

 
 
 
 
 
 

Big biology projects warm up to preprints ▶

30 November 2016
 
 

Consortium backed by US National Institutes of Health is first major biology programme to mandate online publication of results ahead of peer review. Read More ▶

 
 
 
 
 
 

UK moves closer to allowing 'three-parent' babies ▶

30 November 2016
 
 

Scientists say mitochondrial-replacement therapy is ready for tests in the clinic. Read More ▶

 
 
 
 
 
 
 
 
 
  • More Stories  
 
 
 
 
 
 

Can old computers bring Palestinians and Israelis together? ▶

30 November 2016
 
 

Some of the most toxic refuse from modern society ends up in poor communities. Researchers are helping one area in the Middle East clean up its electronic-waste problem. Read More ▶

 
 
 
 
 
 

Tracking the Trump transition, agency by agency ▶

30 November 2016
 
 

Nature's list of the key issues and appointments facing US government science agencies. Read More ▶

 
 
 
 
 
 

Chernobyl's shield, dodo skeleton and HIV vaccines ▶

30 November 2016
 
 

The week in science: 25 November–1 December 2016. Read More ▶

 
 
 
 
 
 

Experimental treatments aim to prevent brain damage in babies ▶

30 November 2016
 
 

Advances in neuroscience are driving the development of therapies that could save thousands of the most vulnerable patients. Read More ▶

 
 
 
 
 
 

Trump's pick for US health secretary has pushed to cut science spending ▶

29 November 2016
 
 

Tom Price, Republican congressman from Georgia, has a thin track-record on science and research issues. Read More ▶

 
 
 
 
 
 

Science Europe lobby group hit by sudden exodus ▶

29 November 2016
 
 

Brussels-based advocacy group aimed to provide single voice for scientists in the EU – but is losing members. Read More ▶

 
 
 
 
 
 

Speedy Antarctic drills start hunt for Earth's oldest ice ▶

29 November 2016
 
 

British team is first to seek site of 1.5-million-year-old sample. Read More ▶

 
 
 
 
 
 

Weaponized antibodies use new tricks to fight cancer ▶

29 November 2016
 
 

Next generation of Trojan-horse drugs designed to minimize damage to healthy cells. Read More ▶

 
 
 
 
 
 

Post-truth: a guide for the perplexed ▶

28 November 2016
 
 

If politicians can lie without condemnation, what are scientists to do? Kathleen Higgins offers some explanation. Read More ▶

 
 
 
 
 
 

Living cells bind silicon and carbon for the first time ▶

24 November 2016
 
 

Modified bacterial enzyme taught to make bonds that evolution avoids. Read More ▶

 
 
 
 
 
 

Failed Alzheimer's trial does not kill leading theory of disease ▶

23 November 2016
 
 

The drug, and others based on the 'amyloid hypothesis', are still being tested in other, different trials. Read More ▶

 
 
 
 
 
 

UK scientists excited by surprise £2-billion government windfall ▶

23 November 2016
 
 

Cash to include fund modelled on DARPA, the US defence department's research arm — but how much will go to basic research is unclear. Read More ▶

 
 
 
 
 
 
 
 
 
 
 

Inside View ▶

Advertisement Feature
 
 
 

Short and informative Q&As with leaders in science and technology.

 
 
 
 
 
 
 
  • Jobs  
 
 
 
 

naturejobs.com

naturejobs.com Science jobs of the week

 
 
 

Post-doctoral fellows

 
 

KU Leuven, The Laboratory for Cell Death Research & Therapy (CDRT) 

 
 
 
 
 

Postdoctoral Fellow in Bioinformatics

 
 

Swiss Tropical Institute 

 
 
 
 
 

Junior Group Leaders Positions

 
 

CRUK Manchester Institute  

 
 
 
 
 

Postdoctoral Scientist

 
 

Medical Research Council 

 
 
 
 

No matter what your career stage, student, postdoc or senior scientist, you will find articles on naturejobs.com to help guide you in your science career. Keep up-to-date with the latest sector trends, vote in our reader poll and sign-up to receive the monthly Naturejobs newsletter.

 
 
 
 
 
     
 

Your email address is in the Nature News Weekly Alert mailing list.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact subscriptions@nature.com

For print subscription enquiries, please contact feedback@nature.com

Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's offices:
Principal offices: London - New York - Tokyo
Worldwide offices: Basingstoke - Boston - Buenos Aires - Delhi - Hong Kong - Madrid - Melbourne - Munich - Paris - San Francisco - Seoul - Washington DC

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

 

No comments: